PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01).

Shu-Zhong Cui,Han Liang,Yong Li,Yanbing Zhou,Kaixiong Tao,Zhiwei Zhou,Guoxin Li,Peiyu Li,Baojun Zhou,Hongliang Yao,Zheng Peng,Bin Xiong,Minghui Pang,Shirong Cai,Jin Wan,Bin Liang,Ziying Lei,Jiping Wang

PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01).

2020

Shu-Zhong Cui
Han Liang
Yong Li
Yanbing Zhou
Kaixiong Tao
Zhiwei Zhou
Guoxin Li
Peiyu Li
Baojun Zhou
Hongliang Yao
Zheng Peng
Bin Xiong
Minghui Pang
Shirong Cai
Jin Wan
Bin Liang
Ziying Lei
Jiping Wang

4538Background: Gastric cancer remains the 3rd leading cancer related death worldwide due to early disease recurrence. We hypothesize that hyperthermic intraperitoneal chemotherapy (HIPEC) may effe...

Keywords:

Surgery
Cancer
Hyperthermic intraperitoneal chemotherapy
Clinical trial
Radical gastrectomy
locally advanced
d2 lymphadenectomy
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations